Covered recipient · General Payments record
KAYLA MASHBURN AKERS
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2023–2024
$646.62
- Reported across 24 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $405.83 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $170.26 | 6 |
| Melinta Therapeutics, Inc. | $162.21 | 5 |
| GlaxoSmithKline, LLC. | $25.99 | 1 |
| Lilly USA, LLC | $16.96 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.95 | 1 |
| Novo Nordisk AS | $13.46 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (15)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Amgen Inc. | $124.46 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111511593 | CMS |
| Amgen Inc. | $9.09 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1111511591 | CMS |
| Amgen Inc. | $5.92 | 05/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117186230 | CMS |
| Amgen Inc. | $18.17 | 05/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117186232 | CMS |
| Amgen Inc. | $6.25 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117186234 | CMS |
| Amgen Inc. | $6.37 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117186236 | CMS |
| GlaxoSmithKline, LLC. | $25.99 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116481099 | CMS |
| Lilly USA, LLC | $16.96 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135766871 | CMS |
| Melinta Therapeutics, LLC | $0.94 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140478891 | CMS |
| Melinta Therapeutics, LLC | $16.92 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140481070 | CMS |
| Melinta Therapeutics, LLC | $1.13 | 05/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140478945 | CMS |
| Melinta Therapeutics, LLC | $18.76 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140481944 | CMS |
| Melinta Therapeutics, LLC | $124.46 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1140487563 | CMS |
| Novo Nordisk Inc | $13.46 | 12/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108571742 | CMS |
| Takeda Pharmaceuticals U.S.A., Inc. | $16.95 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1137704869 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.